Saudi Arabias King Saud hospital successfully deploys AiroCide air purifying technology

The NASA developed AiroCide technology uses innovative various pathogen killing techniques based primarily on photo catalytic oxidation (PCO) to destroy highly harmful airborne microbes. Successfully deployed and used since well over 15+ years, Airocide efficacy claims are backed by clinical documented evidences from government institutions, hospitals, major universities, and the healthcare industry in general including published peer reviews. The same AiroCide systems have now been successfully put to use in the King Saud Hospital for infectious deseases in Riyadh, Kingdom of Saudi Arabia after a fool proof efficacy test.

The test was initiated under the direction of the Directorate of Health (Riyadh) and under the direct supervision of the Ministry of Health (MOH), Kingdom Of Saudi Arabia, Ministry of Health Affairs as well as the hospital to test the air quality in the Tuberculosis (TB) ward. The dreaded disease is making a comeback in many countries today, particularly amongst the homeless, those in prison, and those rendered susceptible because of HIV infection.

– independent and hospital test results showed a reduction in the number of airborne bacteria by 76 percent and that of mold/fungi by 71 percent over a 60 hour test period when the AiroCide units were at work as compared to a baseline reading prior to the activation of AiroCide. In addition, post installation the hospital staff found that the area smelt fresher due to the reduction of Volatile Organic Compounds (VOCs). The presence of VOCs increases in the environment due to the frequent use of hand sanitizers located across the ward.

These VOCs are generated in the form of phenol which is known to cause fatigue and red eyes in individuals who come in constant contact with this carbolic acid. Phenol and its vapor are corrosive to the eyes, the skin and the respiratory tract. AiroCide is proven to eliminate all types of VOCs from the indoor environment including phenol – details Tareque A. Pirzada, President, International Business, Akida Holdings LLC.

He further adds, AiroCide’s low cost implementation and maintenance should be considered when weighing the cost/benefit analysis of reduced nosocomial infections. It is our belief that the reduction and prevention of such infections will translate into significant savings for the hospital, patient and/or public health system.

AiroCide, the air improvement system is an exclusive NASA technology product that eliminates rather than trapping the contaminants. It effectively kills all airborne biological contaminants. A titanium dioxide photo catalyst is deployed in the oxidation process and these active elements oxidize volatile organic compounds (VOCs), fungi, mould, organic odour, etc. and kill and decompose pathogens.

In another hospital within the UAE, Post AiroCide installation a detailed study showed that in an operating theatre, the bacterial count dropped by almost 92% within minutes during an orthopedic surgery. Technology has also been deployed in other areas like the emergency rooms, waiting areas, patient rooms, CSSD, ICU and Out Patient departments. The Airocide units have also been successfully set up within the premises of Hamaad Medical Corporation Hospital in Doha, Qatar with the support of Vinod Nair, General Manager, Doha Drugs Store.



No responses yet

Leave a Reply

Your email address will not be published. Required fields are marked *


Latest Comments

No comments to show.